242 related articles for article (PubMed ID: 24736554)
1. miR-221/222 control luminal breast cancer tumor progression by regulating different targets.
Dentelli P; Traversa M; Rosso A; Togliatto G; Olgasi C; Marchiò C; Provero P; Lembo A; Bon G; Annaratone L; Sapino A; Falcioni R; Brizzi MF
Cell Cycle; 2014; 13(11):1811-26. PubMed ID: 24736554
[TBL] [Abstract][Full Text] [Related]
2. Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.
Kim BG; Gao MQ; Choi YP; Kang S; Park HR; Kang KS; Cho NH
Breast Cancer Res; 2012 Jun; 14(3):R88. PubMed ID: 22673183
[TBL] [Abstract][Full Text] [Related]
3. Integrin β4 regulates SPARC protein to promote invasion.
Gerson KD; Shearstone JR; Maddula VSRK; Seligmann BE; Mercurio AM
J Biol Chem; 2012 Mar; 287(13):9835-9844. PubMed ID: 22308039
[TBL] [Abstract][Full Text] [Related]
4. Vimentin-mediated regulation of cell motility through modulation of beta4 integrin protein levels in oral tumor derived cells.
Dmello C; Sawant S; Alam H; Gangadaran P; Tiwari R; Dongre H; Rana N; Barve S; Costea DE; Chaukar D; Kane S; Pant H; Vaidya M
Int J Biochem Cell Biol; 2016 Jan; 70():161-72. PubMed ID: 26646105
[TBL] [Abstract][Full Text] [Related]
5. ADAM-17 expression in breast cancer correlates with variables of tumor progression.
McGowan PM; Ryan BM; Hill AD; McDermott E; O'Higgins N; Duffy MJ
Clin Cancer Res; 2007 Apr; 13(8):2335-43. PubMed ID: 17438092
[TBL] [Abstract][Full Text] [Related]
6. Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation.
Bon G; Folgiero V; Bossi G; Felicioni L; Marchetti A; Sacchi A; Falcioni R
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3280-7. PubMed ID: 16740748
[TBL] [Abstract][Full Text] [Related]
7. miR-720 is a downstream target of an ADAM8-induced ERK signaling cascade that promotes the migratory and invasive phenotype of triple-negative breast cancer cells.
Das SG; Romagnoli M; Mineva ND; Barillé-Nion S; Jézéquel P; Campone M; Sonenshein GE
Breast Cancer Res; 2016 Apr; 18(1):40. PubMed ID: 27039296
[TBL] [Abstract][Full Text] [Related]
8. Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a.
Finlay-Schultz J; Cittelly DM; Hendricks P; Patel P; Kabos P; Jacobsen BM; Richer JK; Sartorius CA
Oncogene; 2015 Jul; 34(28):3676-87. PubMed ID: 25241899
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.
Li W; Liu C; Zhao C; Zhai L; Lv S
Int J Oncol; 2016 Mar; 48(3):1155-64. PubMed ID: 26781040
[TBL] [Abstract][Full Text] [Related]
10. MiR-126 regulated breast cancer cell invasion by targeting ADAM9.
Wang CZ; Yuan P; Li Y
Int J Clin Exp Pathol; 2015; 8(6):6547-53. PubMed ID: 26261534
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-152 targets ADAM17 to suppress NSCLC progression.
Su Y; Wang Y; Zhou H; Lei L; Xu L
FEBS Lett; 2014 May; 588(10):1983-8. PubMed ID: 24780186
[TBL] [Abstract][Full Text] [Related]
12. Estrogen Enhances the Cell Viability and Motility of Breast Cancer Cells through the ERα-ΔNp63-Integrin β4 Signaling Pathway.
Ho JY; Chang FW; Huang FS; Liu JM; Liu YP; Chen SP; Liu YL; Cheng KC; Yu CP; Hsu RJ
PLoS One; 2016; 11(2):e0148301. PubMed ID: 26845172
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
[TBL] [Abstract][Full Text] [Related]
14. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
Sultan AS; Brim H; Sherif ZA
Cancer Sci; 2008 Feb; 99(2):272-9. PubMed ID: 18271926
[TBL] [Abstract][Full Text] [Related]
15. Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer.
Diaz LK; Cristofanilli M; Zhou X; Welch KL; Smith TL; Yang Y; Sneige N; Sahin AA; Gilcrease MZ
Mod Pathol; 2005 Sep; 18(9):1165-75. PubMed ID: 15920552
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
17. miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer.
Hwang MS; Yu N; Stinson SY; Yue P; Newman RJ; Allan BB; Dornan D
PLoS One; 2013; 8(6):e66502. PubMed ID: 23776679
[TBL] [Abstract][Full Text] [Related]
18. Use of RNA interference to inhibit integrin (alpha6beta4)-mediated invasion and migration of breast carcinoma cells.
Lipscomb EA; Dugan AS; Rabinovitz I; Mercurio AM
Clin Exp Metastasis; 2003; 20(6):569-76. PubMed ID: 14598892
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.
Tsai WC; Hsu PW; Lai TC; Chau GY; Lin CW; Chen CM; Lin CD; Liao YL; Wang JL; Chau YP; Hsu MT; Hsiao M; Huang HD; Tsou AP
Hepatology; 2009 May; 49(5):1571-82. PubMed ID: 19296470
[TBL] [Abstract][Full Text] [Related]
20. MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Liu Q; Jiang J; Fu Y; Liu T; Yu Y; Zhang X
Biomed Pharmacother; 2018 Sep; 105():420-427. PubMed ID: 29879625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
